WHO guidelines on protecting workers from potential risks of manufactured nanomaterials

WHO guidelines on protecting workers from potential risks of manufactured nanomaterials

The term nanomaterials refers to materials that have at least one dimension (height, width or length) that is smaller than 100 nanometres (10-7 metre), which is about the size of a virus particle. This particular size dimension represents a major characteristic of manufactured nanomaterials (MNMs)....

Descripción completa

Detalles Bibliográficos
Autor principal: World Health Organization (author)
Autor Corporativo: World Health Organization, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Geneva : World Health Organization 2017.
Materias:
Nanostructured materials.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009816688206719
Tabla de Contenidos:
  • Glossary
  • Abbreviations and acronyms
  • Executive summary
  • Guiding principles Best practice Methods
  • Recommendations
  • A. Assess health hazards of MNMs
  • B. Assess exposure to MNMs C Control exposure to MNMs
  • D. Health surveillance
  • E. Training and involvement of workers
  • 1. Introduction
  • 1.1. The health burden from manufactured nanomaterials
  • 1.2. Scope of the guidelines and key questions
  • 1.3. WHO guidelines relating to this topic
  • 1.4. Other international programmes on MNM safety
  • 1.5. Target audience
  • 2. Process for guideline development
  • 2.1. Getting started
  • 2.2. Evidence required to address scoping questions
  • 2.3. Summary of evidence review process
  • 2.3.1. The systematic review process
  • 2.3.2. Assessment of overall quality of evidence
  • 2.4. From evidence to recommendations
  • 2.4.1. General process
  • 2.4.2. Workers'values and preferences
  • 3. Individuals and partners involved in guideline development
  • 3.1. WHO Guideline Steering Group
  • 3.2. Guideline Development Group (GDG)
  • 3.3. Systematic review teams
  • 3.4. External Review Group
  • 3.5. Management of conflicts of interest
  • 4. Formulating the recommendations
  • 4.1.Focusofthe recommendations 4.2. Guiding principles
  • 4.2.1. Precautionary approach
  • 4.2.2. Hierarchy of controls
  • 5. Best practice
  • 5.1. Classification of MNMs
  • 5.2. Worker involvement
  • 5.3. Additional training and education of workers
  • 6. Specific recommendations
  • 6.1. Assess health hazards of MNMs
  • 6.2. Assess exposure to MNMs
  • 6.3. Control exposure to MNMs
  • 6.3.1. Focus on prevention of inhalation of MNMs
  • 6.3.2. Use controls to reduce the level of exposure
  • 6.4. Health surveillance
  • From evidence to recommendation
  • Summary of findings: health examinations of workers exposed to MNMs
  • Quality of the evidence
  • Implementation guidance, research recommendation
  • 6.5. Training and involvement of workers
  • Summary of findings: training and involvement of workers
  • Evidence summary
  • Research recommendation
  • 7. Implementation of the guidelines
  • 8. Updating the guidelines
  • References
  • Annex 1: List of proposed occupational exposure limit (OEL) values for MNMs
  • Annex 2: Steering group, guideline development group, systematic review teams
  • and external review group
  • Annex 3: Summary of evidence, routes of exposure to MNMs.

Ejemplares similares